14 Drugs Approved for Primary Care in 2020
Get a quick look at 14 of the many FDA-approved drugs in 2020 for conditions commonly seen in primary care.
The year 2020 has been one-of-a-kind as the novel coronavirus disease 2019 (COVID-19) began to spread globally just after the new year and "social distancing" has become everyday language.
Just like this unique year, there were a number of drugs approved by the US Food and Drug Administration (FDA) that were first-in-class or novel in another way in all 4 quarters of 2020. For example, the first and only FDA-approved COVID-19 treatment; the first adjuvanted, cell-based flu vaccine for use in persons aged ≥6 months; and a first-in-class adenosine triphosphate-citrate lyase inhibitor to treat heterozygous familial hypercholesterolemia. In the slides below, we recap these drugs and 11 more to prepare primary care clinicians for 2021.
